Stroke Prevention in Atrial Fibrillation The Role of Oral Anticoagulation

被引:12
|
作者
Mtwesi, Viwe [1 ]
Amit, Guy [1 ]
机构
[1] McMaster Univ, Hamilton Gen Hosp, Dept Med, Div Cardiol, 237 Barton St East, Hamilton, ON L8L 2X2, Canada
关键词
Atrial fibrillation; Stroke prevention; Anticoagulation; NOAC; Warfarin; DIRECT-CURRENT CARDIOVERSION; PREDICTING STROKE; ISCHEMIC-STROKE; ELECTRICAL CARDIOVERSION; RISK STRATIFICATION; TREATED PATIENTS; DIRECT THROMBIN; LOW-INTENSITY; PLUS ASPIRIN; WARFARIN;
D O I
10.1016/j.mcna.2019.05.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oral anticoagulation significantly reduces the risk of stroke in patients with atrial fibrillation (AF), and the decision to initiate therapy is based on assessing the patient's yearly risk of stroke. Although warfarin remains the drug of choice in patients with AF and artificial mechanical valves, the novel anticoagulation agents are becoming the drug of choice for all other patients with AF, because of their efficacy, safety, and ease of use. This article summarizes the current evidence for stroke prevention in AF, including valvular AF, subclinical AF, AF in patients with renal insufficiency, as well as stroke prevention around AF cardioversion.
引用
下载
收藏
页码:847 / +
页数:17
相关论文
共 50 条
  • [1] The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention
    Neundoerfer, B.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2008, 76 (07) : 383 - 384
  • [2] Stroke Prevention in Atrial Fibrillation Oral Anticoagulation: Myths and Facts
    Gruebler, Beate
    NERVENHEILKUNDE, 2013, 32 (12) : 968 - 969
  • [3] Anticoagulation for Stroke Prevention in Atrial Fibrillation
    Krepostman, Nicolas
    Kramer, Holly J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (05) : 561 - 563
  • [5] Oral anticoagulation and stroke in atrial fibrillation
    Epstein, EF
    Natarajan, I
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (24): : 2360 - 2361
  • [6] Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease
    Ballegaard, Ellen Linnea Freese
    Olesen, Jonas Bjerring
    Kamper, Anne-Lise
    Feldt-Rasmussen, Bo
    Gislason, Gunnar
    Torp-Pedersen, Christian
    Carlson, Nicholas
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (02)
  • [7] Primary and secondary stroke prevention in nonrheumatic atrial fibrillation by oral anticoagulation
    Stöllberger, C
    Finsterer, J
    EUROPEAN NEUROLOGY, 2003, 50 (03) : 127 - 135
  • [8] Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation
    Garcia, David A.
    THROMBOSIS RESEARCH, 2012, 129 (01) : 9 - 16
  • [9] Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation
    Piazza, Gregory
    Karipineni, Neelima
    Goldberg, Howard S.
    Jenkins, Kathryn L.
    Goldhaber, Samuel Z.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (20) : 2444 - 2446
  • [10] ANTICOAGULATION FOR ATRIAL-FIBRILLATION AND STROKE PREVENTION
    BOYSEN, G
    NEUROEPIDEMIOLOGY, 1993, 12 (05) : 280 - 284